TLR4 and diabetes mellitus: For instance, in research relating to diabetes, KLF7 can directly bind to the promoter region in IL-6 and accelerate the overexpression of IL-6 in inflammatory signaling TLR4/NF-kB/IL-6, thereby causing inflammation (Wang et al., 2017; Zhang et al., 2018).